R. Stephens

发表

A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party.

D. Machin, N. Bleehen, D. Girling, 1992, British Journal of Cancer.

Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC). Medical Research Council Lung Cancer Working Party.

D. Machin, D. Girling, R. Stephens, 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma.

D. Girling, R. Stephens, W. Fox, 1985, British Journal of Cancer.

A simulated sequential analysis based on data from two MRC trials.

J. Whitehead, D. Machin, R. Stephens, 1993, British Journal of Cancer.

Acute leukaemia after busulphan.

D. Girling, R. Stephens, W. Fox, 1977, British medical journal.

Studies of case-finding for pulmonary tuberculosis in outpatients at 4 district hospitals in Kenya.

R. Stephens, J. Darbyshire, W. Fox, 1985, Tubercle.

How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung Cancer Working Party.

W F Whimster, D Lamb, B. Corrin, 1993, Thorax.

An assessment of the carcinogenicity of isoniazid in patients with pulmonary tuberculosis.

R. Stephens, W. Fox, J. Peto, 1976, Tubercle.

Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.

D. Girling, R. Stephens, D. Machin, 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party.

D. Machin, N. Bleehen, D. Girling, 1996, British Journal of Cancer.

Survey of the sputum cytology service in England and Wales.

D. Girling, R. Stephens, O. Husain, 1975, Thorax.

5-year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus.

R. Stephens, W. Fox, H. Stott, 1976, British Journal of Cancer.

An investigation of the chest radiographs in a controlled trial of busulphan, cyclophosphamide, and a placebo after resection for carcinoma of the lung.

R. Stephens, G. Simon, W. Fox, 1976, Thorax.